Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1991-03-27
1999-06-15
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242231, 4352351, 435236, 435237, 435238, 435239, A61K 39215, A61K 39225, C12N 700
Patent
active
059119993
ABSTRACT:
A method for preventing canine coronavirus in dogs is disclosed which comprises administering to a dog a live or inactivated vaccine prepared from transmissible gastroenteritis virus of swine (a TGEV vaccine). An inactivated vaccine composition for use in such a method and a process for the manufacture of the inactivated vaccine composition are described.
REFERENCES:
patent: 4070453 (1978-01-01), Bordt et al.
patent: 4335105 (1982-06-01), Gough
patent: 4466957 (1984-08-01), Hjorth et al.
patent: 4567042 (1986-01-01), Acree
patent: 4567043 (1986-01-01), Acree
patent: 4904468 (1990-02-01), Gill et al.
Wood et al, Veterinary Microbiology, volume 4, pp. 11-16, 1979.
Wage et al, Current Topics in Microbiol Immunology, volume 99, pp. 165-200, 1982.
Horzinck et al, Infection and Immunity, volume 37, No. 3, pp. 1148-1155, Sep. 1982.
Garwes et al, J. Gen. Virol., volume 52, pp. 153-157, 1981.
White et al, J. Clin. Micro.; volume 24, pp. 527-531, Oct. 1986.
Siddell et al, J. Gen. Virol. volume 64, pp. 761-776, 1983.
White et al, J. Clin. Micro. volume 24, pp. 527-531, Oct. 1986.
Woods et al, Am. J. Vet. Res. volume 47, pp. 1239-1242, Jun. 1986.
Pedersens et al, Archive of Virology, volume 58, pp. 45-53, 1978.
Barlough et al, Laboratory Animal Science, volume 34, No. 8. pp. 592-597, 1984.
R. Woods, et al., "Immune Response in Sows Given Transmissible Gastroenteritis Virus or Canine Coronavirus", 47 Am. J. Vet. Res. 1239-42, (Jun. 1986) ;.
L. White, et al., "IN Vitro Effect of Ascorbic Acid on Infectivity of Herpesviruses and Paramyxoviruses", 24 J. Clin. Micro. 527-31 (Oct. 1986).
Murata, A., et al., Chem. Abs. 107:36455u (1987), & Agric. Biol. Chem, 51 (3), 933-4 (1987).
Woods, R.D., et al., Biological Abs., 82:53821 (1986) & Amer. J. Vet. Res., 47 (6) : 1239-1242 (1986).
Bordt Dale
Draayer Hans
Mohamed Abdel
Pfizer Inc.
Tsang Cecilia J.
LandOfFree
Vaccine based on TGEV for protection of dogs against canine coro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine based on TGEV for protection of dogs against canine coro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine based on TGEV for protection of dogs against canine coro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-401011